Recombinant Protein Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

Published on : Aug-2017 | List of Tables : 281 | List of Figures : 105 | No. of Pages : 170 | Report Code : FACT186MR | Format : ppt pdf Excel Word

Proteins resulting from expression of recombinant DNA (rDNA), within living cells, are known as recombinant proteins. rDNAs are DNA molecules that are formed by laboratory procedures of genetic recombination, to bring genetic material together from multiple sources. DNA sequences used for constructing recombinant DNA molecules originate from any species. If the DNA sequences do not occur in nature, they can be created through chemical synthesis of DNA, further incorporating them into recombinant molecules.

After cell engineering and genetic engineering technology, recombinant protein, which is constructed from the creature body, is now at the forefront of biotechnology production. Recombinant protein technology has become the standard, with current shifts in focus from bulk production method to post-production techniques, promising enhanced stability and delivery. Recombinant protein is highly effective, and plays an indispensable role in treatment of certain diseases, such as hemophilia (excluding blood coagulation factor that has an extremely limited source). Most of the recombinant protein drugs used are derived from human proteins, or, mutants of human proteins, for compensating functional proteins in vivo defects, or, to increase protein function in a body. This renders recombinant proteins with a significantly higher safety than small molecules, leading towards a higher approval rate.

Clinical trial period for recombinant protein is shorter as compared to small molecule drugs. This further helps in enhancing the patient protection, providing pharmaceutical companies with longer exclusive sales time. These factors have fuelled the development as well as demand for recombinant protein. Recombinant proteins are targeted at major diseases including endocrine diseases, cardiovascular diseases, cancer, and viral diseases. Moreover, the global market for recombinant proteins has larger extension space. Few approval drugs are available in the recombinant protein market, with no substitute products in therapeutic areas. However, owing to higher financial barriers, and technical barriers, recombinant proteins are subject to high costs. Replicating recombinant proteins is a more difficult task than that of small molecule chemicals. Fact.MR’s report projects the global market for recombinant protein to expand at an average CAGR during the forecast period (2017 to 2022). The market is estimated to account for nearly US$ 460 Mn revenues by 2022-end.

Market Taxonomy

Product Type

End User

Application

Immune Checkpoint Regulators

Biopharmaceutical Companies

Drug Discovery & Development

Chemokines

Contract Research Organizations (CROs)

Basic Research

Growth Factors

Academic & Research Institutes

Toxicity Screening

Cytokines

Forensic Science Laboratories

Biopharmaceutical Production

Colony Stimulating Factors

Food & Beverage Companies

Drug Screening

Hormones

Diagnostic Centers

Tissue Engineering

Enzymes & Inhibitors

Others

Forensic Testing

Other

   

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

North America to Remain Dominant in the Market

North America will continue to retain its dominance in the global recombinant protein market, with sales projected to reach nearly US$ 150 Mn by 2022-end. Europe is estimated to be the second most lucrative market for recombinant protein throughout the forecast period. The market in Middle East & Africa (MEA) is anticipated to witness a sluggish expansion through 2022.

Recombinant proteins factoring molecular growth will remain the most lucrative product in the market, followed by checkpoint regulators. In addition, sales of growth factors, and cytokines are poised to exhibit similar CAGRs through 2022. However, sales of chemokines are estimated to register the fastest expansion through 2022. Demand for enzymes & inhibitors will continue to be sluggish throughout the forecast period.

Although academic & research institutes are expected to remain the largest end-users of recombinant proteins in terms of revenues, sales in biopharmaceutical companies will register the highest CAGR compared to all the other end-user segments through 2022. Revenues from sales of recombinant proteins in academic & research institutes will account for over one-third market share during 2017 to 2022.

Recombinant proteins will continue to find the largest application in basic research activities. Revenues from recombinant proteins for basic research are expected to account for around US$ 270 Mn by 2022-end. Drug discovery & development, and toxicity screening are estimated to emerge as the fastest growing applications of recombinant proteins. Sales of recombinant proteins for application in forensic testing are estimated to register the lowest CAGR through 2022.

Competition Tracking

Leading players in the global recombinant protein market include Abcam plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., BPS Bioscience Inc., PerkinElmer, Inc., Crown Bioscience, Inc., GenScript Corporation, Merck Millipore Limited, Sigma Aldrich, and Thermo Fisher Scientific, Inc.

NoteThe insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

1. Global Recombinant Proteins Market - Executive Summary

2. Global Recombinant Proteins Market Overview
2.1. Introduction
       2.1.1. Global Recombinant Proteins Market Taxonomy
       2.1.2. Global Recombinant Proteins Market Definition
2.2. Global Recombinant Proteins Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Recombinant Proteins Market Y-o-Y Growth
2.3. Global Recombinant Proteins Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis 
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Recombinant Proteins Market Analysis and Forecast By Product Type 
3.1. Global Recombinant Proteins Market Size and Forecast By Product Type, 2012-2022
       3.1.1. Immune Checkpoint Regulators Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Chemokines Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region
       3.1.3. Growth Factors Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.3.1. Revenue (US$ Mn) Comparison, By Region
                3.1.3.2. Market Share Comparison, By Region
                3.1.3.3. Y-o-Y growth Comparison, By Region
       3.1.4. Cytokines Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.4.1. Revenue (US$ Mn) Comparison, By Region
                3.1.4.2. Market Share Comparison, By Region
                3.1.4.3. Y-o-Y growth Comparison, By Region
       3.1.5. Colony Stimulating Factors Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.5.1. Revenue (US$ Mn) Comparison, By Region
                3.1.5.2. Market Share Comparison, By Region
                3.1.5.3. Y-o-Y growth Comparison, By Region
       3.1.6. Hormones Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.6.1. Revenue (US$ Mn) Comparison, By Region
                3.1.6.2. Market Share Comparison, By Region
                3.1.6.3. Y-o-Y growth Comparison, By Region
       3.1.7. Enzymes & Inhibitors Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.7.1. Revenue (US$ Mn) Comparison, By Region
                3.1.7.2. Market Share Comparison, By Region
                3.1.7.3. Y-o-Y growth Comparison, By Region
       3.1.8. Other  Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.8.1. Revenue (US$ Mn) Comparison, By Region
                3.1.8.2. Market Share Comparison, By Region
                3.1.8.3. Y-o-Y growth Comparison, By Region

4. Global Recombinant Proteins Market Analysis and Forecast By End User 
4.1. Global Recombinant Proteins Market Size and Forecast By End User, 2012-2022
       4.1.1. Biopharmaceutical Companies Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Contract Research Organizations (CROs) Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Academic & Research Institutes Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region
       4.1.4. Forensic Science Laboratories Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.4.1. Revenue (US$ Mn) Comparison, By Region
                4.1.4.2. Market Share Comparison, By Region
                4.1.4.3. Y-o-Y growth Comparison, By Region
       4.1.5. Food & Beverage Companies Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.5.1. Revenue (US$ Mn) Comparison, By Region
                4.1.5.2. Market Share Comparison, By Region
                4.1.5.3. Y-o-Y growth Comparison, By Region
       4.1.6. Diagnostic Centers Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.6.1. Revenue (US$ Mn) Comparison, By Region
                4.1.6.2. Market Share Comparison, By Region
                4.1.6.3. Y-o-Y growth Comparison, By Region
       4.1.7. Others Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.7.1. Revenue (US$ Mn) Comparison, By Region
                4.1.7.2. Market Share Comparison, By Region
                4.1.7.3. Y-o-Y growth Comparison, By Region

5. Global Recombinant Proteins Market Analysis and Forecast By Application 
5.1. Global Recombinant Proteins Market Size and Forecast By Application, 2012-2022
       5.1.1. Drug Discovery & Development Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.1.1. Revenue (US$ Mn) Comparison, By Region
                5.1.1.2. Market Share Comparison, By Region
                5.1.1.3. Y-o-Y growth Comparison, By Region
       5.1.2. Basic Research Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.2.1. Revenue (US$ Mn) Comparison, By Region
                5.1.2.2. Market Share Comparison, By Region
                5.1.2.3. Y-o-Y growth Comparison, By Region
       5.1.3. Toxicity Screening Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.3.1. Revenue (US$ Mn) Comparison, By Region
                5.1.3.2. Market Share Comparison, By Region
                5.1.3.3. Y-o-Y growth Comparison, By Region
       5.1.4. Biopharmaceutical Production Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.4.1. Revenue (US$ Mn) Comparison, By Region
                5.1.4.2. Market Share Comparison, By Region
                5.1.4.3. Y-o-Y growth Comparison, By Region
       5.1.5. Drug Screening Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.5.1. Revenue (US$ Mn) Comparison, By Region
                5.1.5.2. Market Share Comparison, By Region
                5.1.5.3. Y-o-Y growth Comparison, By Region
       5.1.6. Tissue Engineering Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.6.1. Revenue (US$ Mn) Comparison, By Region
                5.1.6.2. Market Share Comparison, By Region
                 5.1.6.3. Y-o-Y growth Comparison, By Region
       5.1.7. Forensic Testing Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.7.1. Revenue (US$ Mn) Comparison, By Region
                5.1.7.2. Market Share Comparison, By Region
                5.1.7.3. Y-o-Y growth Comparison, By Region

6. Global Recombinant Proteins Market Analysis and Forecast By Region
6.1. Global Recombinant Proteins Market Size and Forecast, 2012-2022
       6.1.1. North America Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.1.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.1.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.1.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.2. Latin America Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.2.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.2.2. Revenue (US$ Mn) Comparison, By End User 
                 6.1.2.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.3. Europe Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.3.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.3.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.3.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.4. Japan Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.4.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.4.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.4.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.5. APEJ Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.5.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.5.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.5.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.6. MEA Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.6.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.6.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.6.3. Revenue (US$ Mn) Comparison, By Application 

7. North America Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
7.1. US Recombinant Proteins Market Size and Forecast, 2012-2022
       7.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       7.1.2. Revenue (US$ Mn) Comparison, By End User 
       7.1.3. Revenue (US$ Mn) Comparison, By Application 
7.2. Canada Recombinant Proteins Market Size and Forecast, 2012-2022
       7.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       7.2.2. Revenue (US$ Mn) Comparison, By End User 
       7.2.3. Revenue (US$ Mn) Comparison, By Application 

8. Latin America Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
8.1. Brazil Recombinant Proteins Market Size and Forecast, 2012-2022
       8.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       8.1.2. Revenue (US$ Mn) Comparison, By End User 
       8.1.3. Revenue (US$ Mn) Comparison, By Application 
8.2. Mexico Recombinant Proteins Market Size and Forecast, 2012-2022
       8.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       8.2.2. Revenue (US$ Mn) Comparison, By End User 
       8.2.3. Revenue (US$ Mn) Comparison, By Application 
8.3. Argentina Recombinant Proteins Market Size and Forecast, 2012-2022
       8.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       8.3.2. Revenue (US$ Mn) Comparison, By End User 
       8.3.3. Revenue (US$ Mn) Comparison, By Application 

9. Europe Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
9.1. Germany Recombinant Proteins Market Size and Forecast, 2012-2022
       9.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.1.2. Revenue (US$ Mn) Comparison, By End User 
       9.1.3. Revenue (US$ Mn) Comparison, By Application 
9.2. UK Recombinant Proteins Market Size and Forecast, 2012-2022
       9.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.2.2. Revenue (US$ Mn) Comparison, By End User 
       9.2.3. Revenue (US$ Mn) Comparison, By Application 
9.3. France Recombinant Proteins Market Size and Forecast, 2012-2022
       9.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.3.2. Revenue (US$ Mn) Comparison, By End User 
       9.3.3. Revenue (US$ Mn) Comparison, By Application 
9.4. Spain Recombinant Proteins Market Size and Forecast, 2012-2022
       9.4.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.4.2. Revenue (US$ Mn) Comparison, By End User 
       9.4.3. Revenue (US$ Mn) Comparison, By Application 
9.5. Italy Recombinant Proteins Market Size and Forecast, 2012-2022
       9.5.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.5.2. Revenue (US$ Mn) Comparison, By End User 
       9.5.3. Revenue (US$ Mn) Comparison, By Application 
9.6. Nordic Recombinant Proteins Market Size and Forecast, 2012-2022
       9.6.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.6.2. Revenue (US$ Mn) Comparison, By End User 
       9.6.3. Revenue (US$ Mn) Comparison, By Application 

10. Japan Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
10.1. Japan  Recombinant Proteins Market Size and Forecast, 2012-2022
       10.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       10.1.2. Revenue (US$ Mn) Comparison, By End User 
       10.1.3. Revenue (US$ Mn) Comparison, By Application 

11. APEJ Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
11.1. China Recombinant Proteins Market Size and Forecast, 2012-2022
       11.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.1.2. Revenue (US$ Mn) Comparison, By End User 
       11.1.3. Revenue (US$ Mn) Comparison, By Application 
11.2. India Recombinant Proteins Market Size and Forecast, 2012-2022
       11.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.2.2. Revenue (US$ Mn) Comparison, By End User 
       11.2.3. Revenue (US$ Mn) Comparison, By Application 
11.3. Malaysia Recombinant Proteins Market Size and Forecast, 2012-2022
       11.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.3.2. Revenue (US$ Mn) Comparison, By End User 
       11.3.3. Revenue (US$ Mn) Comparison, By Application 
11.4. Thailand Recombinant Proteins Market Size and Forecast, 2012-2022
       11.4.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.4.2. Revenue (US$ Mn) Comparison, By End User 
       11.4.3. Revenue (US$ Mn) Comparison, By Application 
11.5. Singapore Recombinant Proteins Market Size and Forecast, 2012-2022
       11.5.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.5.2. Revenue (US$ Mn) Comparison, By End User 
       11.5.3. Revenue (US$ Mn) Comparison, By Application 
11.6. Australia Recombinant Proteins Market Size and Forecast, 2012-2022
       11.6.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.6.2. Revenue (US$ Mn) Comparison, By End User 
       11.6.3. Revenue (US$ Mn) Comparison, By Application 

12. MEA Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
12.1. GCC Countries Recombinant Proteins Market Size and Forecast, 2012-2022
       12.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.1.2. Revenue (US$ Mn) Comparison, By End User 
       12.1.3. Revenue (US$ Mn) Comparison, By Application 
12.2. South Africa Recombinant Proteins Market Size and Forecast, 2012-2022
       12.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.2.2. Revenue (US$ Mn) Comparison, By End User 
       12.2.3. Revenue (US$ Mn) Comparison, By Application 
12.3. Nigeria Recombinant Proteins Market Size and Forecast, 2012-2022
       12.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.3.2. Revenue (US$ Mn) Comparison, By End User 
       12.3.3. Revenue (US$ Mn) Comparison, By Application 
12.4. Israel Recombinant Proteins Market Size and Forecast, 2012-2022
       12.4.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.4.2. Revenue (US$ Mn) Comparison, By End User 
       12.4.3. Revenue (US$ Mn) Comparison, By Application 

13. Global Recombinant Proteins Market Competition Landscape and Company Profile
13.1. Company Share Analysis By Region
13.2. Abcam plc
       13.2.1. Company Overview
       13.2.2. Recombinant Proteins Market Product Type list
       13.2.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.2.4. Key Developments
       13.2.5. SWOT Analysis
13.3. A.M.S. Biotechnology (Europe) Limited
       13.3.1. Company Overview
       13.3.2. Recombinant Proteins Market Product Type list
       13.3.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.3.4. Key Developments
       13.3.5. SWOT Analysis
13.4. Bio-Rad Laboratories, Inc
       13.4.1. Company Overview
       13.4.2. Recombinant Proteins Market Product Type list
       13.4.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.4.4. Key Developments
       13.4.5. SWOT Analysis
13.5. BPS Bioscience Inc
       13.5.1. Company Overview
       13.5.2. Recombinant Proteins Market Product Type list
       13.5.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.5.4. Key Developments
       13.5.5. SWOT Analysis
13.6. PerkinElmer, Inc.
       13.6.1. Company Overview
       13.6.2. Recombinant Proteins Market Product Type list
       13.6.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.6.4. Key Developments
       13.6.5. SWOT Analysis
13.7. Crown Bioscience, Inc.
       13.7.1. Company Overview
       13.7.2. Recombinant Proteins Market Product Type list
       13.7.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.7.4. Key Developments
       13.7.5. SWOT Analysis
13.8. GenScript Corporation
       13.8.1. Company Overview
       13.8.2. Recombinant Proteins Market Product Type list
       13.8.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.8.4. Key Developments
       13.8.5. SWOT Analysis
13.9. Merck Millipore Limited
       13.9.1. Company Overview
       13.9.2. Recombinant Proteins Market Product Type list
       13.9.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.9.4. Key Developments
       13.9.5. SWOT Analysis
13.10. Sigma Aldrich
       13.10.1. Company Overview
       13.10.2. Recombinant Proteins Market Product Type list
       13.10.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.10.4. Key Developments
       13.10.5. SWOT Analysis
13.11. Thermo Fisher Scientific, Inc
       13.11.1. Company Overview
       13.11.2. Recombinant Proteins Market Product Type list
       13.11.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.11.4. Key Developments
       13.11.5. SWOT Analysis

14. Research Methodology

15. Secondary and Primary Sources

16. Assumptions and Acronyms

17. Disclaimer

TABLE 1 Global Recombinant Proteins Market Value (US$ Mn), 2012-2016
TABLE 2 Global Recombinant Proteins Market Value (US$ Mn), 2017-2022
TABLE 3 Global Recombinant Proteins Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Immune Checkpoint Regulators Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Immune Checkpoint Regulators Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Immune Checkpoint Regulators Segment Market Share, By Region 2012-2016
TABLE 7 Global Immune Checkpoint Regulators Segment Market Share, By Region 2017-2022
TABLE 8 Global Immune Checkpoint Regulators Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Chemokines Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Chemokines Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Chemokines Segment Market Share, By Region 2012-2016
TABLE 12 Global Chemokines Segment Market Share, By Region 2017-2022
TABLE 13 Global Chemokines Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Growth Factors Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Growth Factors Segment Value (US$ Mn), By Region 2017-2022
TABLE 16 Global Growth Factors Segment Market Share, By Region 2012-2016
TABLE 17 Global Growth Factors Segment Market Share, By Region 2017-2022
TABLE 18 Global Growth Factors Segment Y-o-Y, By Region 2015-2022
TABLE 19 Global Cytokines Segment Value (US$ Mn), By Region 2012-2016
TABLE 20 Global Cytokines Segment Value (US$ Mn), By Region 2017-2022
TABLE 21 Global Cytokines Segment Market Share, By Region 2012-2016
TABLE 22 Global Cytokines Segment Market Share, By Region 2017-2022
TABLE 23 Global Cytokines Segment Y-o-Y, By Region 2015-2022
TABLE 24 Global Colony Stimulating Factors Segment Value (US$ Mn), By Region 2012-2016
TABLE 25 Global Colony Stimulating Factors Segment Value (US$ Mn), By Region 2017-2022
TABLE 26 Global Colony Stimulating Factors Segment Market Share, By Region 2012-2016
TABLE 27 Global Colony Stimulating Factors Segment Market Share, By Region 2017-2022
TABLE 28 Global Colony Stimulating Factors Segment Y-o-Y, By Region 2015-2022
TABLE 29 Global Hormones Segment Value (US$ Mn), By Region 2012-2016
TABLE 30 Global Hormones Segment Value (US$ Mn), By Region 2017-2022
TABLE 31 Global Hormones Segment Market Share, By Region 2012-2016
TABLE 32 Global Hormones Segment Market Share, By Region 2017-2022
TABLE 33 Global Hormones Segment Y-o-Y, By Region 2015-2022
TABLE 34 Global Enzymes & Inhibitors Segment Value (US$ Mn), By Region 2012-2016
TABLE 35 Global Enzymes & Inhibitors Segment Value (US$ Mn), By Region 2017-2022
TABLE 36 Global Enzymes & Inhibitors Segment Market Share, By Region 2012-2016
TABLE 37 Global Enzymes & Inhibitors Segment Market Share, By Region 2017-2022
TABLE 38 Global Enzymes & Inhibitors Segment Y-o-Y, By Region 2015-2022
TABLE 39 Global Other  Segment Value (US$ Mn), By Region 2012-2016
TABLE 40 Global Other  Segment Value (US$ Mn), By Region 2017-2022
TABLE 41 Global Other  Segment Market Share, By Region 2012-2016
TABLE 42 Global Other  Segment Market Share, By Region 2017-2022
TABLE 43 Global Other  Segment Y-o-Y, By Region 2015-2022
TABLE 44 Global Biopharmaceutical Companies Segment Value (US$ Mn), By Region 2012-2016
TABLE 45 Global Biopharmaceutical Companies Segment Value (US$ Mn), By Region 2017-2022
TABLE 46 Global Biopharmaceutical Companies Segment Market Share, By Region 2012-2016
TABLE 47 Global Biopharmaceutical Companies Segment Market Share, By Region 2017-2022
TABLE 48 Global Biopharmaceutical Companies Segment Y-o-Y, By Region 2015-2022
TABLE 49 Global Contract Research Organizations (CROs) Segment Value (US$ Mn), By Region 2012-2016
TABLE 50 Global Contract Research Organizations (CROs) Segment Value (US$ Mn), By Region 2017-2022
TABLE 51 Global Contract Research Organizations (CROs) Segment Market Share, By Region 2012-2016
TABLE 52 Global Contract Research Organizations (CROs) Segment Market Share, By Region 2017-2022
TABLE 53 Global Contract Research Organizations (CROs) Segment Y-o-Y, By Region 2015-2022
TABLE 54 Global Academic & Research Institutes Segment Value (US$ Mn), By Region 2012-2016
TABLE 55 Global Academic & Research Institutes Segment Value (US$ Mn), By Region 2017-2022
TABLE 56 Global Academic & Research Institutes Segment Market Share, By Region 2012-2016
TABLE 57 Global Academic & Research Institutes Segment Market Share, By Region 2017-2022
TABLE 58 Global Academic & Research Institutes Segment Y-o-Y, By Region 2015-2022
TABLE 59 Global Forensic Science Laboratories Segment Value (US$ Mn), By Region 2012-2016
TABLE 60 Global Forensic Science Laboratories Segment Value (US$ Mn), By Region 2017-2022
TABLE 61 Global Forensic Science Laboratories Segment Market Share, By Region 2012-2016
TABLE 62 Global Forensic Science Laboratories Segment Market Share, By Region 2017-2022
TABLE 63 Global Forensic Science Laboratories Segment Y-o-Y, By Region 2015-2022
TABLE 64 Global Food & Beverage Companies Segment Value (US$ Mn), By Region 2012-2016
TABLE 65 Global Food & Beverage Companies Segment Value (US$ Mn), By Region 2017-2022
TABLE 66 Global Food & Beverage Companies Segment Market Share, By Region 2012-2016
TABLE 67 Global Food & Beverage Companies Segment Market Share, By Region 2017-2022
TABLE 68 Global Food & Beverage Companies Segment Y-o-Y, By Region 2015-2022
TABLE 69 Global Diagnostic Centers Segment Value (US$ Mn), By Region 2012-2016
TABLE 70 Global Diagnostic Centers Segment Value (US$ Mn), By Region 2017-2022
TABLE 71 Global Diagnostic Centers Segment Market Share, By Region 2012-2016
TABLE 72 Global Diagnostic Centers Segment Market Share, By Region 2017-2022
TABLE 73 Global Diagnostic Centers Segment Y-o-Y, By Region 2015-2022
TABLE 74 Global Others Segment Value (US$ Mn), By Region 2012-2016
TABLE 75 Global Others Segment Value (US$ Mn), By Region 2017-2022
TABLE 76 Global Others Segment Market Share, By Region 2012-2016
TABLE 77 Global Others Segment Market Share, By Region 2017-2022
TABLE 78 Global Others Segment Y-o-Y, By Region 2015-2022
TABLE 79 Global Drug Discovery & Development Segment Value (US$ Mn), By Region 2012-2016
TABLE 80 Global Drug Discovery & Development Segment Value (US$ Mn), By Region 2017-2022
TABLE 81 Global Drug Discovery & Development Segment Market Share, By Region 2012-2016
TABLE 82 Global Drug Discovery & Development Segment Market Share, By Region 2017-2022
TABLE 83 Global Drug Discovery & Development Segment Y-o-Y, By Region 2015-2022
TABLE 84 Global Basic Research Segment Value (US$ Mn), By Region 2012-2016
TABLE 85 Global Basic Research Segment Value (US$ Mn), By Region 2017-2022
TABLE 86 Global Basic Research Segment Market Share, By Region 2012-2016
TABLE 87 Global Basic Research Segment Market Share, By Region 2017-2022
TABLE 88 Global Basic Research Segment Y-o-Y, By Region 2015-2022
TABLE 89 Global Toxicity Screening Segment Value (US$ Mn), By Region 2012-2016
TABLE 90 Global Toxicity Screening Segment Value (US$ Mn), By Region 2017-2022
TABLE 91 Global Toxicity Screening Segment Market Share, By Region 2012-2016
TABLE 92 Global Toxicity Screening Segment Market Share, By Region 2017-2022
TABLE 93 Global Toxicity Screening Segment Y-o-Y, By Region 2015-2022
TABLE 94 Global Biopharmaceutical Production Segment Value (US$ Mn), By Region 2012-2016
TABLE 95 Global Biopharmaceutical Production Segment Value (US$ Mn), By Region 2017-2022
TABLE 96 Global Biopharmaceutical Production Segment Market Share, By Region 2012-2016
TABLE 97 Global Biopharmaceutical Production Segment Market Share, By Region 2017-2022
TABLE 98 Global Biopharmaceutical Production Segment Y-o-Y, By Region 2015-2022
TABLE 99 Global Drug Screening Segment Value (US$ Mn), By Region 2012-2016
TABLE 100 Global Drug Screening Segment Value (US$ Mn), By Region 2017-2022
TABLE 101 Global Drug Screening Segment Market Share, By Region 2012-2016
TABLE 102 Global Drug Screening Segment Market Share, By Region 2017-2022
TABLE 103 Global Drug Screening Segment Y-o-Y, By Region 2015-2022
TABLE 104 Global Tissue Engineering Segment Value (US$ Mn), By Region 2012-2016
TABLE 105 Global Tissue Engineering Segment Value (US$ Mn), By Region 2017-2022
TABLE 106 Global Tissue Engineering Segment Market Share, By Region 2012-2016
TABLE 107 Global Tissue Engineering Segment Market Share, By Region 2017-2022
TABLE 108 Global Tissue Engineering Segment Y-o-Y, By Region 2015-2022
TABLE 109 Global Forensic Testing Segment Value (US$ Mn), By Region 2012-2016
TABLE 110 Global Forensic Testing Segment Value (US$ Mn), By Region 2017-2022
TABLE 111 Global Forensic Testing Segment Market Share, By Region 2012-2016
TABLE 112 Global Forensic Testing Segment Market Share, By Region 2017-2022
TABLE 113 Global Forensic Testing Segment Y-o-Y, By Region 2015-2022
TABLE 114 North America Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 115 North America Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 116 North America Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 117 North America Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 118 North America Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 119 North America Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 120 Latin America Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 121 Latin America Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 122 Latin America Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 123 Latin America Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 124 Latin America Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 125 Latin America Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 126 Europe Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 127 Europe Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 128 Europe Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 129 Europe Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 130 Europe Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 131 Europe Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 132 Japan Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 133 Japan Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 134 Japan Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 135 Japan Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 136 Japan Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 137 Japan Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 138 APEJ Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 139 APEJ Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 140 APEJ Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 141 APEJ Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 142 APEJ Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 143 APEJ Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 144 MEA Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 145 MEA Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 146 MEA Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 147 MEA Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 148 MEA Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 149 MEA Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 150 US Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 151 US Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 152 US Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 153 US Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 154 US Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 155 US Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 156 Canada Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 157 Canada Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 158 Canada Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 159 Canada Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 160 Canada Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 161 Canada Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 162 Brazil Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 163 Brazil Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 164 Brazil Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 165 Brazil Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 166 Brazil Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 167 Brazil Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 168 Mexico Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 169 Mexico Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 170 Mexico Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 171 Mexico Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 172 Mexico Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 173 Mexico Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 174 Argentina Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 175 Argentina Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 176 Argentina Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 177 Argentina Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 178 Argentina Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 179 Argentina Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 180 Germany Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 181 Germany Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 182 Germany Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 183 Germany Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 184 Germany Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 185 Germany Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 186 UK Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 187 UK Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 188 UK Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 189 UK Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 190 UK Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 191 UK Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 192 France Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 193 France Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 194 France Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 195 France Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 196 France Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 197 France Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 198 Spain Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 199 Spain Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 200 Spain Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 201 Spain Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 202 Spain Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 203 Spain Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 204 Italy Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 205 Italy Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 206 Italy Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 207 Italy Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 208 Italy Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 209 Italy Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 210 Nordic Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 211 Nordic Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 212 Nordic Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 213 Nordic Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 214 Nordic Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 215 Nordic Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 216 Japan  Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 217 Japan  Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 218 Japan  Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 219 Japan  Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 220 Japan  Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 221 Japan  Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 222 China Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 223 China Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 224 China Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 225 China Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 226 China Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 227 China Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 228 India Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 229 India Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 230 India Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 231 India Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 232 India Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 233 India Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 234 Malaysia Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 235 Malaysia Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 236 Malaysia Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 237 Malaysia Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 238 Malaysia Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 239 Malaysia Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 240 Thailand Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 241 Thailand Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 242 Thailand Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 243 Thailand Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 244 Thailand Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 245 Thailand Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 246 Singapore Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 247 Singapore Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 248 Singapore Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 249 Singapore Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 250 Singapore Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 251 Singapore Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 252 Australia Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 253 Australia Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 254 Australia Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 255 Australia Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 256 Australia Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 257 Australia Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 258 GCC Countries Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 259 GCC Countries Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 260 GCC Countries Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 261 GCC Countries Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 262 GCC Countries Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 263 GCC Countries Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 264 South Africa Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 265 South Africa Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 266 South Africa Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 267 South Africa Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 268 South Africa Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 269 South Africa Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 270 Nigeria Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 271 Nigeria Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 272 Nigeria Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 273 Nigeria Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 274 Nigeria Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 275 Nigeria Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
TABLE 276 Israel Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
TABLE 277 Israel Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
TABLE 278 Israel Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
TABLE 279 Israel Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
TABLE 280 Israel Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
TABLE 281 Israel Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022

FIG. 1 Global Recombinant Proteins Market Value (US$ Mn), 2012-2016
FIG. 2 Global Recombinant Proteins Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Recombinant Proteins Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Immune Checkpoint Regulators Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Immune Checkpoint Regulators Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Immune Checkpoint Regulators Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Chemokines Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Chemokines Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Chemokines Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Growth Factors Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Growth Factors Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Growth Factors Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Cytokines Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Cytokines Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Cytokines Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 16 Global Colony Stimulating Factors Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 17 Global Colony Stimulating Factors Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 18 Global Colony Stimulating Factors Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 19 Global Hormones Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 20 Global Hormones Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 21 Global Hormones Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 22 Global Enzymes & Inhibitors Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 23 Global Enzymes & Inhibitors Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 24 Global Enzymes & Inhibitors Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 25 Global Other  Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 26 Global Other  Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 27 Global Other  Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 28 Global Biopharmaceutical Companies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 29 Global Biopharmaceutical Companies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 30 Global Biopharmaceutical Companies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 31 Global Contract Research Organizations (CROs) Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 32 Global Contract Research Organizations (CROs) Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 33 Global Contract Research Organizations (CROs) Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 34 Global Academic & Research Institutes Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 35 Global Academic & Research Institutes Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 36 Global Academic & Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 37 Global Forensic Science Laboratories Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 38 Global Forensic Science Laboratories Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 39 Global Forensic Science Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 40 Global Food & Beverage Companies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 41 Global Food & Beverage Companies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 42 Global Food & Beverage Companies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 43 Global Diagnostic Centers Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 44 Global Diagnostic Centers Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 45 Global Diagnostic Centers Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 46 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 47 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 48 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 49 Global Drug Discovery & Development Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 50 Global Drug Discovery & Development Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 51 Global Drug Discovery & Development Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 52 Global Basic Research Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 53 Global Basic Research Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 54 Global Basic Research Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 55 Global Toxicity Screening Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 56 Global Toxicity Screening Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 57 Global Toxicity Screening Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 58 Global Biopharmaceutical Production Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 59 Global Biopharmaceutical Production Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 60 Global Biopharmaceutical Production Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 61 Global Drug Screening Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 62 Global Drug Screening Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 63 Global Drug Screening Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 64 Global Tissue Engineering Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 65 Global Tissue Engineering Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 66 Global Tissue Engineering Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 67 Global Forensic Testing Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 68 Global Forensic Testing Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 69 Global Forensic Testing Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 70 North America Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
FIG. 71 North America Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
FIG. 72 North America Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
FIG. 73 North America Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
FIG. 74 North America Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
FIG. 75 North America Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
FIG. 76 Latin America Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
FIG. 77 Latin America Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
FIG. 78 Latin America Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
FIG. 79 Latin America Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
FIG. 80 Latin America Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
FIG. 81 Latin America Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
FIG. 82 Europe Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
FIG. 83 Europe Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
FIG. 84 Europe Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
FIG. 85 Europe Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
FIG. 86 Europe Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
FIG. 87 Europe Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
FIG. 88 Japan Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
FIG. 89 Japan Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
FIG. 90 Japan Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
FIG. 91 Japan Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
FIG. 92 Japan Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
FIG. 93 Japan Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
FIG. 94 APEJ Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
FIG. 95 APEJ Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
FIG. 96 APEJ Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
FIG. 97 APEJ Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
FIG. 98 APEJ Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
FIG. 99 APEJ Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022
FIG. 100 MEA Recombinant Proteins Market Value (US$ Mn), By Product Type 2012-2016
FIG. 101 MEA Recombinant Proteins Market Value (US$ Mn), By Product Type 2017-2022
FIG. 102 MEA Recombinant Proteins Market Value (US$ Mn), By End User 2012-2016
FIG. 103 MEA Recombinant Proteins Market Value (US$ Mn), By End User 2017-2022
FIG. 104 MEA Recombinant Proteins Market Value (US$ Mn), By Application 2012-2016
FIG. 105 MEA Recombinant Proteins Market Value (US$ Mn), By Application 2017-2022

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Recombinant Protein Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022